Massimetti, C. et al. 2021. Effects of secondary hyperparathyroidism treatment on hemoglobin levels and erythropoietin doses in hemodialysis patients. Journal of Clinical Nephrology. 5, 3 (Oct. 2021), 088–094. DOI:https://doi.org/10.29328/journal.jcn.1001081.